[Form 4] Phibro Animal Health Corporation Insider Trading Activity
Anthony Andolino, Vice President Finance and Treasurer of Phibro Animal Health Corp (PAHC), received an award of 1,793 restricted stock units (RSUs) on 08/15/2025. Each RSU represents a contingent right to one share of Class A common stock and was granted at a $0 price. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment through each vesting date. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Andolino on 08/19/2025.
Anthony Andolino, Vice President Finance e Tesoriere di Phibro Animal Health Corp (PAHC), ha ricevuto un premio di 1.793 unit脿 di azioni vincolate (RSU) il 15/08/2025. Ciascuna RSU rappresenta il diritto condizionato a una azione di azioni ordinarie di Classe A ed 猫 stata concessa a un prezzo di $0. Le RSU maturano in rate sostanzialmente uguali in ciascuno dei primi tre anniversari del 1掳 agosto 2025, subordinatamente alla prosecuzione del rapporto di lavoro fino a ciascuna data di maturazione. Il Modulo 4 猫 stato firmato da un procuratore (attorney-in-fact) per conto del Sig. Andolino il 19/08/2025.
Anthony Andolino, Vicepresidente de Finanzas y Tesorero de Phibro Animal Health Corp (PAHC), recibi贸 una adjudicaci贸n de 1.793 unidades de acciones restringidas (RSU) el 15/08/2025. Cada RSU representa el derecho contingente a una acci贸n de acciones ordinarias Clase A y se otorg贸 a un precio de $0. Las RSU se consolidan en cuotas sustancialmente iguales en cada uno de los tres primeros aniversarios del 1 de agosto de 2025, sujeto a la continuidad del empleo hasta cada fecha de consolidaci贸n. El Formulario 4 fue firmado por un apoderado en nombre del Sr. Andolino el 19/08/2025.
Phibro Animal Health Corp(PAHC) 鞛 雼措嫻 攵�靷灔 瓴� 鞛鞚挫偓鞚� Anthony Andolino電� 2025雲� 8鞗� 15鞚检棎 1,793欤检潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 臧� RSU電� 韥措灅鞀� A 氤错喌欤检潣 1欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 鞚橂頃橂┌, 攵�鞐� 臧�瓴╈潃 $0鞓�鞀惦媹雼�. RSU電� 2025雲� 8鞗� 1鞚检潉 鞁滌瀾鞙茧 頄ロ泟 觳� 3臧� 旮半厫鞚� 臧侁皝鞐� 鞁れ鞝侅溂搿� 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅�, 臧� 氩犾姢韺呾澕旯岇 瓿犾毄鞚� 鞙犾霅橃柎鞎� 頃╇媹雼�. 鞏戩嫕(Form 4)鞚� 2025雲� 8鞗� 19鞚检棎 Mr. Andolino毳� 雽�鞁犿暣 雽�毽秾鞛愲 靹滊獏霅橃棃鞀惦媹雼�.
Anthony Andolino, Vice-pr茅sident Finances et Tr茅sorier de Phibro Animal Health Corp (PAHC), a re莽u une attribution de 1 793 unit茅s d'actions restreintes (RSU) le 15/08/2025. Chaque RSU repr茅sente le droit conditionnel 脿 une action ordinaire de cat茅gorie A et a 茅t茅 attribu茅e au prix de 0 $. Les RSU acquerront des droits en parts sensiblement 茅gales 脿 chacune des trois premi猫res dates d'anniversaire du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi jusqu'脿 chaque date d'acquisition. Le formulaire 4 a 茅t茅 sign茅 par un mandataire au nom de M. Andolino le 19/08/2025.
Anthony Andolino, Vice President Finance und Schatzmeister von Phibro Animal Health Corp (PAHC), erhielt am 15.08.2025 eine Zuteilung von 1.793 Restricted Stock Units (RSUs). Jede RSU stellt das bedingte Recht auf eine Aktie der Klasse A Stammaktien dar und wurde zu einem Preis von $0 gew盲hrt. Die RSUs werden in im Wesentlichen gleichen Raten an den ersten drei Jahrestagen des 1. August 2025 f盲llig, vorbehaltlich der fortgesetzten Anstellung bis zu den jeweiligen Vesting-Terminen. Das Formular 4 wurde am 19.08.2025 von einem Bevollm盲chtigten im Namen von Herrn Andolino unterzeichnet.
- Officer received 1,793 RSU grant representing a contingent right to one Class A share each
- Vesting schedule spans three years, which supports retention and aligns executive incentives
- Timely SEC disclosure filed and signed by attorney-in-fact on 08/19/2025
- None.
Insights
TL;DR: Routine officer equity grant aligns executive incentives; disclosure is standard and non-dilutive immediately.
The filing reports a standard grant of 1,793 RSUs to the company鈥檚 VP Finance and Treasurer. These RSUs are contingent rights to Class A shares and vest over three years in equal installments, which is a common retention and incentive structure. The grant price is reported as $0, indicating stock units rather than an option exercise. From a governance perspective, the disclosure is timely and conforms to Section 16 reporting requirements; there is no immediate share issuance or cash transaction disclosed that would materially change capital structure today.
TL;DR: Material impact to investors appears limited; this is an operational compensation disclosure, not a market-moving event.
The transaction involves 1,793 RSUs granted to an executive, vesting over three years. The report does not show any sale or exercise that would affect outstanding shares today. Absent information on total outstanding shares or aggregate insider holdings, this grant alone provides limited insight into dilution or ownership changes. The Form 4 fulfills disclosure rules but does not indicate a change in control, liquidity event, or other material corporate action.
Anthony Andolino, Vice President Finance e Tesoriere di Phibro Animal Health Corp (PAHC), ha ricevuto un premio di 1.793 unit脿 di azioni vincolate (RSU) il 15/08/2025. Ciascuna RSU rappresenta il diritto condizionato a una azione di azioni ordinarie di Classe A ed 猫 stata concessa a un prezzo di $0. Le RSU maturano in rate sostanzialmente uguali in ciascuno dei primi tre anniversari del 1掳 agosto 2025, subordinatamente alla prosecuzione del rapporto di lavoro fino a ciascuna data di maturazione. Il Modulo 4 猫 stato firmato da un procuratore (attorney-in-fact) per conto del Sig. Andolino il 19/08/2025.
Anthony Andolino, Vicepresidente de Finanzas y Tesorero de Phibro Animal Health Corp (PAHC), recibi贸 una adjudicaci贸n de 1.793 unidades de acciones restringidas (RSU) el 15/08/2025. Cada RSU representa el derecho contingente a una acci贸n de acciones ordinarias Clase A y se otorg贸 a un precio de $0. Las RSU se consolidan en cuotas sustancialmente iguales en cada uno de los tres primeros aniversarios del 1 de agosto de 2025, sujeto a la continuidad del empleo hasta cada fecha de consolidaci贸n. El Formulario 4 fue firmado por un apoderado en nombre del Sr. Andolino el 19/08/2025.
Phibro Animal Health Corp(PAHC) 鞛 雼措嫻 攵�靷灔 瓴� 鞛鞚挫偓鞚� Anthony Andolino電� 2025雲� 8鞗� 15鞚检棎 1,793欤检潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)毳� 攵�鞐皼鞎橃姷雼堧嫟. 臧� RSU電� 韥措灅鞀� A 氤错喌欤检潣 1欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 鞚橂頃橂┌, 攵�鞐� 臧�瓴╈潃 $0鞓�鞀惦媹雼�. RSU電� 2025雲� 8鞗� 1鞚检潉 鞁滌瀾鞙茧 頄ロ泟 觳� 3臧� 旮半厫鞚� 臧侁皝鞐� 鞁れ鞝侅溂搿� 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅�, 臧� 氩犾姢韺呾澕旯岇 瓿犾毄鞚� 鞙犾霅橃柎鞎� 頃╇媹雼�. 鞏戩嫕(Form 4)鞚� 2025雲� 8鞗� 19鞚检棎 Mr. Andolino毳� 雽�鞁犿暣 雽�毽秾鞛愲 靹滊獏霅橃棃鞀惦媹雼�.
Anthony Andolino, Vice-pr茅sident Finances et Tr茅sorier de Phibro Animal Health Corp (PAHC), a re莽u une attribution de 1 793 unit茅s d'actions restreintes (RSU) le 15/08/2025. Chaque RSU repr茅sente le droit conditionnel 脿 une action ordinaire de cat茅gorie A et a 茅t茅 attribu茅e au prix de 0 $. Les RSU acquerront des droits en parts sensiblement 茅gales 脿 chacune des trois premi猫res dates d'anniversaire du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi jusqu'脿 chaque date d'acquisition. Le formulaire 4 a 茅t茅 sign茅 par un mandataire au nom de M. Andolino le 19/08/2025.
Anthony Andolino, Vice President Finance und Schatzmeister von Phibro Animal Health Corp (PAHC), erhielt am 15.08.2025 eine Zuteilung von 1.793 Restricted Stock Units (RSUs). Jede RSU stellt das bedingte Recht auf eine Aktie der Klasse A Stammaktien dar und wurde zu einem Preis von $0 gew盲hrt. Die RSUs werden in im Wesentlichen gleichen Raten an den ersten drei Jahrestagen des 1. August 2025 f盲llig, vorbehaltlich der fortgesetzten Anstellung bis zu den jeweiligen Vesting-Terminen. Das Formular 4 wurde am 19.08.2025 von einem Bevollm盲chtigten im Namen von Herrn Andolino unterzeichnet.
FAQ
What did PAHC insider Anthony Andolino report on Form 4?
When do the RSUs granted to Anthony Andolino vest?
Did the Form 4 show any securities sold by Anthony Andolino?
What is the reported price for the RSU grant?
What is Anthony Andolino鈥檚 role at PAHC as stated in the filing?
